PPIB and Alzheimer disease: Together with Aβ-targeting vaccination, the pharmacological inhibition of the two β- and γ-secretases Aβ-forming enzymes stood during the past decades as the principal and most relevant therapeutic tracks aimed at preventing, slowing down or curing Alzheimer’s disease.